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EDITORIAL 
Molecular Pharmacology of the GABAA Receptor 
  The GABAA receptor is a member of the Cys-loop family of transmitter-gated ion channels. GABAA receptors respond to 
synaptically-released or ambient transmitter with a conformational change, resulting in the opening of the gate that allows 
movement  of  small  anions  through  the  channel.  Under  most  circumstances,  GABAA  receptor-mediated  signaling  leads  to 
hyperpolarization in the mature brain. The normal functioning of the receptor is critical to cellular function, while errors in 
GABAA receptor activity can systemically manifest as seizures, anxiety disorders and others. The pharmacology of the GABAA 
receptor is remarkably rich. The receptor is a target for benzodiazepines, steroids, barbiturates, and a number of other classes of 
compounds, some of which are used clinically as anesthetics, anxiolytics, or anticonvulsants. The actions of the drugs are in 
many cases dependent on the subunit composition of the GABAA receptor. Thus, understanding how the existing therapeutics 
act can pave way to new drugs with improved specificity and reduced side effects. This Hot Topic Issue presents an overview 
of molecular pharmacology of the GABAA receptor focusing on three classes of positive  modulators: general  anesthetics, 
benzodiazepines, and neuroactive steroids. 
  Paul Garcia, Scott Kolesky and Andrew Jenkins provide an introduction to GABAA receptors, and discuss the actions of 
major classes of volatile and intravenous anesthetics. The manuscript addresses the relationship between subunit composition of 
the receptor and modulation, and summarizes the data from work on mutated receptors on the location of the anesthetic binding 
cavity.  Matt Bianchi presents a summary of the actions of benzodiazepines on the GABAA receptor. The major effect of 
benzodiazepines  is  to  enhance  the  affinity  of  the  receptor  to  the  transmitter.  The  manuscript  is  aimed  at  comparing  and 
contrasting  the  ability of benzodiazepines to  modulate  currents under conditions resembling synaptic conditions  and tonic 
exposure to GABA.  Finally, Gustav Akk and colleagues discuss the current knowledge about kinetic and structural features of 
GABAA  receptor  modulation  by  potentiating  neuroactive  steroids.  This  class  of  steroids  acts  by  increasing  channel  open 
probability through a set of modifications in the channel open and closed time distributions. The review critically evaluates 
available  experimental  data  discussing  the  possibility  of  a  single  vs.  multiple  interaction  sites  mediating  the  effects  of 
potentiating steroids. 
  This Hot Topics Issue provides an overview of the rapidly developing field of molecular pharmacology of the GABAA 
receptor. The manuscripts focus on several of the numerous positive modulators of the receptor summarizing the present state 
of knowledge and introducing new evidence and novel viewpoints about the kinetic and structural aspects of modulation. It is 
hoped that the presented material will provide an impetus for further research in this area. 
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